Sep 02, 2026 | UCI Beall Applied Innovation

---

Member, Michael Demetriou, MD, PhD - The Sweet Spot in Cancer Immunotherapy

"Once GlyTR grabs hold of a cancer cell, its other end draws a T cell into contact with it and destroys it."

Sep 02, 2026 | UC Irvine In the News

---

Member, Philip Felgner, PhD - What Doctors Want You to Know About the New 'Personalized' Cancer Vaccine Making Headlines

“This is the first large phase 3 study to demonstrate meaningful clinical benefit from an individualized mRNA cancer vaccine.”

Sep 01, 2026 | UC Irvine In the News

---

Members, Francesco Marangoni, PhD; John Lowengrub, PhD - Math and Medicine Join Forces to Solve a Cancer Mystery

Scientists uncover a key cause of immunotherapy failure – and a path to overcoming it

Sep 01, 2026 | UC Irvine In the News

---

Member, Suellen Hopfer, PhD - Social Media: Reading Between the Lines

"...gives us another window into how people are experiencing heat in their daily lives"

Sep 01, 2026 | UCI Beall Applied Innovation

---

Member, Chang Liu, PhD – Is This the Breakthrough Drug Development We’ve Been Waiting For?

His lab developed a system called OrthoRep, which allows proteins to evolve rapidly and continuously inside yeast cells.

Aug 27, 2026

---

Office of Research Launches FundOpp Match

With an AI assist, FundOpp Match filters and matches external funding opportunities to UCI research areas.

Aug 27, 2026 | UC Irvine Digest

---

Member, Shawn Griffin, PharmD - Cancer Treatment Saves Lives Without Dangerous Side Effects

"...existing drugs that may be repurposed..." versus "...developing entirely new drugs."

Aug 24, 2026 | UCI Health

---

Member, Lauren Pinter-Brown, MD - Renowned Lymphoma Physician Thanked by Patient

Video: Anti-Cancer Challenge patient, Bransby Whitton, expresses gratitude for "world-class care”

Aug 24, 2026 | UCI Health

---

Members, Leslie Thompson, PhD; Jefferson Chen, MD, PhD - Behind the World’s First Neural Stem Cell Clinical Trial to Treat Huntington’s Disease

REGEN4HD aims to enroll 21 patients in early stages of the incurable genetic disorder